Molecular imaging of atherosclerosis

Curr Cardiol Rep. 2008 Mar;10(2):121-7. doi: 10.1007/s11886-008-0021-5.

Abstract

Techniques are being developed for clinical molecular imaging of atherosclerosis to identify and characterize vulnerable plaques in each vascular territory. Molecular imaging encompasses multiple imaging modalities that depict cellular and subcellular processes. Molecular imaging can provide a "virtual histology" noninvasively about atherosclerotic disease, characterizing vascular lesions with markers of inflammation, angiogenesis, lipid metabolism, and more.

Publication types

  • Biography
  • Historical Article
  • Review

MeSH terms

  • Arteriosclerosis / diagnosis
  • Arteriosclerosis / diagnostic imaging*
  • Arteriosclerosis / etiology
  • Arteriosclerosis / metabolism
  • Arteriosclerosis / pathology
  • Biotechnology
  • Fluorodeoxyglucose F18
  • History, 20th Century
  • Humans
  • Inflammation / complications
  • Inflammation / diagnostic imaging
  • Inflammation / immunology*
  • Inflammation / metabolism
  • Integrins / metabolism
  • Lipid Metabolism
  • Lipoproteins, LDL / metabolism*
  • Muscle, Smooth, Vascular / metabolism
  • Neovascularization, Pathologic
  • Positron-Emission Tomography / methods
  • Prognosis
  • Radionuclide Imaging / history
  • Radionuclide Imaging / methods
  • Radiopharmaceuticals* / history

Substances

  • Integrins
  • Lipoproteins, LDL
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18

Personal name as subject

  • Georg von Hevesy